Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 252

1.

Treatment with insulin detemir or NPH insulin in children aged 2-5 yr with type 1 diabetes mellitus.

Thalange N, Bereket A, Larsen J, Hiort LC, Peterkova V.

Pediatr Diabetes. 2011 Nov;12(7):632-41. doi: 10.1111/j.1399-5448.2010.00750.x. Epub 2011 Mar 21.

PMID:
21418455
2.

Insulin detemir offers improved glycemic control compared with NPH insulin in people with type 1 diabetes: a randomized clinical trial.

Home P, Bartley P, Russell-Jones D, Hanaire-Broutin H, Heeg JE, Abrams P, Landin-Olsson M, Hylleberg B, Lang H, Draeger E; Study to Evaluate the Administration of Detemir Insulin Efficacy, Safety and Suitability (STEADINESS) Study Group.

Diabetes Care. 2004 May;27(5):1081-7.

PMID:
15111525
4.
5.

Switching from NPH insulin to once-daily insulin detemir in basal-bolus-treated patients with diabetes mellitus: data from the European cohort of the PREDICTIVE study.

Sreenan S, Virkamäki A, Zhang K, Hansen JB; PREDICTIVE study group.

Int J Clin Pract. 2008 Dec;62(12):1971-80. doi: 10.1111/j.1742-1241.2008.01939.x. Erratum in: Int J Clin Pract. 2009 Jan;63(1):176-7:178-80.

PMID:
19166444
6.

Insulin detemir and insulin aspart: a promising basal-bolus regimen for type 2 diabetes.

Raslová K, Bogoev M, Raz I, Leth G, Gall MA, Hâncu N.

Diabetes Res Clin Pract. 2004 Nov;66(2):193-201. Erratum in: Diabetes Res Clin Pract. 2006 Apr;72(1):112.

PMID:
15533587
7.

Insulin analogues in children with Type 1 diabetes: a 52-week randomized clinical trial.

Thalange N, Bereket A, Larsen J, Hiort LC, Peterkova V.

Diabet Med. 2013 Feb;30(2):216-25. doi: 10.1111/dme.12041.

8.

Insulin detemir compared with NPH insulin in children and adolescents with Type 1 diabetes.

Robertson KJ, Schoenle E, Gucev Z, Mordhorst L, Gall MA, Ludvigsson J.

Diabet Med. 2007 Jan;24(1):27-34.

PMID:
17227321
11.

Lower HbA1c after 1 year, in children with type 1 diabetes treated with insulin glargine vs. NPH insulin from diagnosis: a retrospective study.

Salemyr J, Bang P, Örtqvist E.

Pediatr Diabetes. 2011 Aug;12(5):501-5. doi: 10.1111/j.1399-5448.2010.00723.x. Epub 2011 Mar 28.

PMID:
21443584
12.

Insulin detemir lowers the risk of hypoglycaemia and provides more consistent plasma glucose levels compared with NPH insulin in Type 1 diabetes.

Kølendorf K, Ross GP, Pavlic-Renar I, Perriello G, Philotheou A, Jendle J, Gall MA, Heller SR.

Diabet Med. 2006 Jul;23(7):729-35.

PMID:
16842476
13.

Maternal efficacy and safety outcomes in a randomized, controlled trial comparing insulin detemir with NPH insulin in 310 pregnant women with type 1 diabetes.

Mathiesen ER, Hod M, Ivanisevic M, Duran Garcia S, Brøndsted L, Jovanovic L, Damm P, McCance DR; Detemir in Pregnancy Study Group.

Diabetes Care. 2012 Oct;35(10):2012-7. Epub 2012 Jul 30.

14.

Insulin degludec in combination with bolus insulin aspart is safe and effective in children and adolescents with type 1 diabetes.

Thalange N, Deeb L, Iotova V, Kawamura T, Klingensmith G, Philotheou A, Silverstein J, Tumini S, Ocampo Francisco AM, Kinduryte O, Danne T.

Pediatr Diabetes. 2015 May;16(3):164-76. doi: 10.1111/pedi.12263. Epub 2015 Feb 12.

16.
17.

Evaluating the cost-effectiveness of reduced mild hypoglycaemia in subjects with Type 1 diabetes treated with insulin detemir or NPH insulin in Denmark, Sweden, Finland and the Netherlands.

Valentine WJ, Jendle J, Saraheimo M, Thorsteinsson B, Pollock RF, Lammert M.

Diabet Med. 2012 Mar;29(3):303-12. doi: 10.1111/j.1464-5491.2011.03461.x.

PMID:
21951030
18.

Long-acting insulin analogues vs. NPH human insulin in type 1 diabetes. A meta-analysis.

Monami M, Marchionni N, Mannucci E.

Diabetes Obes Metab. 2009 Apr;11(4):372-8. doi: 10.1111/j.1463-1326.2008.00976.x. Review.

PMID:
19267715
19.
20.

Insulin detemir improves glycemic control and reduces hypoglycemia in children with type 1 diabetes: findings from the Turkish cohort of the PREDICTIVE observational study.

Kurtoglu S, Atabek ME, Dizdarer C, Pirgon O, Isguven P, Emek S; PREDICTIVE Turkey Study Group.

Pediatr Diabetes. 2009 Sep;10(6):401-7. doi: 10.1111/j.1399-5448.2008.00497.x. Epub 2009 Feb 11.

PMID:
19220776

Supplemental Content

Support Center